title: Tacrolimus: an effective treatment in refractory psoriatic arthritis following biologic failure.
authors.affiliation: Imperial Clinical Research Facility, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK. mark.lythgoe@nhs.net.
authors.forename: Mark
authors.initials: M
authors.lastname: Lythgoe
authors.affiliation: Imperial Clinical Research Facility, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
authors.forename: Sonya
authors.initials: S
authors.lastname: Abraham
mesh_terms: D018501:Antirheumatic Agents / Q000145:classification / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001799:Blood Sedimentation / Q000187:drug effects; D002097:C-Reactive Protein / Q000032:analysis; D003424:Crohn Disease / Q000150:complications*; D016903:Drug Monitoring; D018432:Drug Resistance, Multiple; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008875:Middle Aged; D016559:Tacrolimus / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D002097:C-Reactive Protein; D016559:Tacrolimus